Which of the following is/are NOT required to be packaged in a child-resistant container?

In this scenario, the key aspect to recognize is the regulations regarding child-resistant packaging as mandated by the Poison Prevention Packaging Act (PPPA). Certain medications are exempt from the requirement to be packaged in child-resistant containers due to their specific characteristics or the way they are typically used.

A container of 30 sublingual nitroglycerin tablets is commonly used for acute angina attacks and is often provided in a non-child-resistant container for accessibility. This facilitates quick administration during a medical emergency, as it allows patients to easily access their medication without the barrier of a child-resistant cap.

A methylprednisolone dose pack containing 21 tablets is another exemption. When medications are prescribed in a blister pack format, as is the case with many corticosteroids, this specific dosage form may not require child-resistant packaging, as it allows easy access for patients who are often dealing with routine usage rather than acute situations.

An albuterol inhaler is also typically exempt because these devices are designed for delivery of medication in emergency situations, and child-resistant packaging may hinder rapid use when needed urgently.

The combination of these exemptions allows for easier access to critical medications that patients may need in emergencies, emphasizing safety and practicality in medication usage. Therefore, none of the items listed require child